Skip to main content
Clinical Trials/NCT03804814
NCT03804814
Terminated
Not Applicable

Assessing a Model for Hepatitis C Elimination: Measuring Patient and Health System Outcomes After Motivational Interviewing Interventions to Increase Treatment Engagement

Nova Scotia Health Authority1 site in 1 country2 target enrollmentMay 21, 2019
ConditionsHepatitis C

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatitis C
Sponsor
Nova Scotia Health Authority
Enrollment
2
Locations
1
Primary Endpoint
HCV Treatment Completion
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.

Registry
clinicaltrials.gov
Start Date
May 21, 2019
End Date
October 4, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lisa Barrett

Assistant Professor

Dalhousie University

Eligibility Criteria

Inclusion Criteria

  • Willingness to participate and provide informed consent
  • Positive HCV RNA Result
  • ≥18 years of age

Exclusion Criteria

  • Unwilling or unable to provide consent
  • Health Care Provider Inclusion Criteria:
  • Willingness to participate and provide informed consent
  • Has a hepatitis C care experience
  • Health Care Provider Exclusion Criteria:
  • Unwilling or unable to provide consent

Outcomes

Primary Outcomes

HCV Treatment Completion

Time Frame: Through study completion, an average of 2 years

To measure the number of patients who complete HCV therapy

Secondary Outcomes

  • Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire(Through study completion, an average of 2 years)
  • Number of unique Hepatitis C related and unrelated health system visits(Through study completion, an average of 2 years)
  • Time from care engagement to treatment initiation(Through study completion, an average of 2 years)
  • Number of scheduled and attended medical care appointments(Through study completion, an average of 2 years)
  • Time to complete prescribed HCV treatment course(Through study completion, an average of 2 years)
  • Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire(Through study completion, an average of 2 years)
  • Percentage of eligible individuals that initiate HCV therapy(Through study completion, an average of 2 years)

Study Sites (1)

Loading locations...

Similar Trials